These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
| ☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
|
| ☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OF 15(D) OF THE SECURITIES
|
|
Delaware
|
|
13-4196940
|
|
(State or other jurisdiction of Incorporation of organization)
|
|
(IRS Employer Identification Number)
|
|
401 Theodore Fremd Avenue, Rye, New York
|
10580
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
(914) 921-1877
|
|
(Registrant’s telephone number, including area code)
|
|
Large accelerated filer ☐
|
Accelerated filer ☐
|
|
Non-accelerated filer ☐ (Do not check if a smaller reporting company)
|
Smaller reporting company ☒
|
|
Emerging growth company ☐
|
|
Class
|
Outstanding at October 14, 2019
|
|
Common Stock, $.01 par value
|
4,859,055
|
|
PART I –FINANCIAL INFORMATION
|
||
|
Page No.
|
||
|
Item 1.
|
1-5
|
|
|
6-7
|
||
|
Item 2.
|
7-8
|
|
|
Item 3.
|
8
|
|
|
Item 4.
|
8-9
|
|
|
PART II – OTHER INFORMATION
|
||
|
Item 1.
|
9
|
|
|
Item 1a.
|
9
|
|
|
Item 2.
|
9
|
|
|
Item 3.
|
9
|
|
|
Item 4.
|
9
|
|
|
Item 5.
|
9
|
|
|
Item 6.
|
10
|
|
|
11
|
||
|
Unaudited Financial Statements
|
|
|
|
Condensed Balance Sheets at September 30, 2019, December 31, 2018 and September 30, 2018
|
2 | |
|
Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2019 and 2018
|
3
|
|
|
Condensed Statements of Cash Flows for the Nine Ended September 30, 2019 and 2018
|
4
|
|
|
Condensed Statement of Shareholders’ Equity for the Three Months Ended September 30, 2019, June 30, 2019, March 31, 2019, December 31, 2018, September 30, 2018, June 30, 2018, and March 31,
2018.
|
5
|
|
|
Notes to Condensed Financial Statements as of September 30, 2019
|
6 | |
|
|
|
September 30,
2019
|
|
|
December 31,
2018
|
|
|
September 30,
2018
|
|
|||
|
ASSETS
|
||||||||||||
|
Current assets:
|
||||||||||||
|
Cash and cash equivalents
|
$
|
79,074
|
$
|
129,635
|
$
|
133,152
|
||||||
|
Prepaid expenses
|
9,875
|
7,454
|
12,613
|
|||||||||
|
Total current assets
|
88,949
|
137,089
|
145,765
|
|||||||||
|
Total assets
|
$
|
88,949
|
$
|
137,089
|
$
|
145,765
|
||||||
|
LIABILITIES
|
||||||||||||
|
Current liabilities:
|
||||||||||||
|
Accrued liabilities
|
$
|
18,193
|
$
|
222
|
$
|
222
|
||||||
|
Total current liabilities
|
18,193
|
222
|
222
|
|||||||||
|
Total liabilities
|
18,193
|
222
|
222
|
|||||||||
|
COMMITMENTS AND CONTINGENCIES
|
||||||||||||
|
SHAREHOLDERS’ EQUITY
|
||||||||||||
|
Preferred stock, $0.01 par value, 1,000,000 shares authorized, none outstanding
|
--
|
--
|
--
|
|||||||||
|
Common stock, $0.01 par value, 100,000,000 shares authorized at September 30, 2019 and 10,000,000 authorized at December 31, 2018 and September 30, 2018, 4,859,055 shares outstanding at all
periods
|
48,591
|
48,591
|
48,591
|
|||||||||
|
Additional paid-in-capital
|
5,937,368
|
5,937,368
|
5,937,368
|
|||||||||
|
Accumulated deficit
|
(5,915,203
|
)
|
(5,849,092
|
)
|
(5,840,416
|
)
|
||||||
|
Total shareholders’ equity
|
70,756
|
136,867
|
145,543
|
|||||||||
|
Total liabilities and shareholders’ equity
|
$
|
88,949
|
$
|
137,089
|
$
|
145,765
|
||||||
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
|||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||
|
Revenues
|
$
|
--
|
$
|
--
|
$
|
--
|
$
|
--
|
||||||||
|
Administrative expenses
|
(32,809
|
)
|
(9,616
|
)
|
(67,819
|
)
|
(48,381
|
)
|
||||||||
|
Other income:
|
||||||||||||||||
|
Interest income
|
461
|
651
|
1,708
|
1,317
|
||||||||||||
|
Net loss before income taxes
|
(32,348
|
)
|
(8,965
|
)
|
(66,111
|
)
|
(47,064
|
)
|
||||||||
|
Income taxes
|
--
|
--
|
--
|
--
|
||||||||||||
|
Net loss
|
$
|
(32,348
|
)
|
$
|
(8.965
|
)
|
$
|
(66,111
|
)
|
$
|
(47,064
|
)
|
||||
|
Net loss per share, basic and diluted
|
$
|
(0.01
|
)
|
$
|
(0.00
|
)
|
$
|
(0.01
|
)
|
$
|
(0.01
|
)
|
||||
|
Shares outstanding, basic and diluted
|
4,859,055
|
4,859,055
|
4,859,055
|
4,430,484
|
||||||||||||
|
Nine Months Ended
September 30,
|
||||||||
|
2019
|
2018
|
|||||||
|
Cash Flows from Operating Activities
|
||||||||
|
Interest income
|
$
|
1,708
|
$
|
1,317
|
||||
|
Cash paid to suppliers
|
(52,269
|
)
|
(65,438
|
)
|
||||
|
Net cash used in operating activities
|
(50,561
|
)
|
(64,121
|
)
|
||||
|
Cash Flows from Financing Activities
|
||||||||
|
Issuance of common stock
|
--
|
180,000
|
||||||
|
Net cash provided by financing activities
|
--
|
180,000
|
||||||
|
Net (decrease) increase in cash and cash equivalents
|
(50,561
|
)
|
115,879
|
|||||
|
Cash and cash equivalents, beginning of the period
|
129,635
|
17,273
|
||||||
|
Cash and cash equivalents, end of the period
|
$
|
79,074
|
$
|
133,152
|
||||
|
Reconciliation of net loss to net cash used in operating activities:
|
||||||||
|
Net loss
|
$
|
(66,111
|
)
|
$
|
(47,064
|
)
|
||
|
Increase in prepaid expenses
|
(2,421
|
)
|
(12,284
|
)
|
||||
|
Increase (decrease) in accrued liabilities
|
17,971
|
(4,773
|
)
|
|||||
|
Net cash used in operating activities
|
$
|
(50,561
|
)
|
$
|
(64,121
|
)
|
||
|
Cash paid for interest
|
$
|
--
|
$
|
--
|
||||
|
Cash paid for income taxes
|
$
|
--
|
$
|
--
|
||||
|
Common Stock
|
Additional
|
|||||||||||||||||||
|
Shares
|
Par
Value
|
Paid in
Capital
|
Accumulated
Deficit
|
Total
|
||||||||||||||||
|
Shareholders’ equity, December 31, 2017
|
3,359,055
|
$
|
33,591
|
$
|
5,772,368
|
$
|
(5,793,352
|
)
|
$
|
12,607
|
||||||||||
|
Sale of common stock
|
1,500,000
|
15,000
|
165,000
|
-
|
180,000
|
|||||||||||||||
|
Net loss for three months ended March 31, 2018
|
--
|
--
|
--
|
(26,976
|
)
|
(26,976
|
)
|
|||||||||||||
|
Shareholders’ equity, March 31, 2018
|
4,859,055
|
48,591
|
5,937,368
|
(5,820,328
|
)
|
165,631
|
||||||||||||||
|
Net loss for three months ended June 30, 2018
|
--
|
--
|
--
|
(11,123
|
)
|
(11,123
|
)
|
|||||||||||||
|
Shareholders’ equity. June 30, 2018
|
4,859,055
|
48,591
|
5,937,368
|
(5,831,451
|
)
|
154,508
|
||||||||||||||
|
Net loss for three months ended September 30, 2018
|
--
|
--
|
--
|
(8,965
|
)
|
(8,965
|
)
|
|||||||||||||
|
Shareholders’ equity. September 30, 2018
|
4,859.055
|
48,591
|
5,937,368
|
(5,840,416
|
)
|
145,543
|
||||||||||||||
|
Net loss for three months ended December 31, 2018
|
--
|
--
|
--
|
(8,676
|
)
|
(8,676
|
)
|
|||||||||||||
|
Shareholders’ equity. December 31, 2018
|
4,859,055
|
48,591
|
5,937,368
|
(5,849,092
|
)
|
136,867
|
||||||||||||||
|
Net loss for three months ended March 31, 2019
|
--
|
--
|
--
|
(22,684
|
)
|
(22,684
|
)
|
|||||||||||||
|
Shareholders’ equity. March 31, 2019
|
4,859,055
|
48,591
|
5,937,368
|
(5.871,776
|
)
|
114,183
|
||||||||||||||
|
Net loss for three months ended June 30, 2019
|
--
|
--
|
--
|
(11,079
|
)
|
(11,079
|
)
|
|||||||||||||
|
Shareholders’ equity. June 30, 2019
|
4,859,055
|
48,591
|
5,937,368
|
(5,882,855
|
)
|
103,104
|
||||||||||||||
|
Net loss for three months ended September 30, 2019
|
--
|
--
|
--
|
(32,348
|
)
|
(32,348
|
)
|
|||||||||||||
|
Shareholders’ equity. September 30, 2019
|
4,859,055
|
$
|
48,591
|
$
|
5,937,368
|
$
|
(5,915,203
|
)
|
$
|
70,756
|
||||||||||
| Note 1. |
Basis of Presentation
|
| Note 2. |
Acquisition of G.Research, LLC
|
| Note 3. |
Significant Accounting Policies
|
|
Note 4.
|
Fair Value of Financial Instruments
|
| Note 5. |
Income Taxes
|
|
Note 6.
|
Commitments and Contingencies
|
| Note 7. |
Shareholders’ Equity
|
|
(a)
|
Evaluation of Disclosure Controls and Procedures
|
|
(b)
|
Changes in Internal Controls
|
|
Acting Chief Executive Officer and Chief Financial Officer Rule 15d-14(a) Certification.
|
||
|
Acting Chief Executive Officer and Chief Financial Officer Section 1350 Certification.
|
||
|
EX-101.INS
|
XBRL INSTANCE DOCUMENT
|
|
|
EX-101.SCH
|
XBRL TAXONOMY EXTENSION SCHEMA
|
|
|
EX-101.PRE
|
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
|
|
|
EX-101.LAB
|
XBRL TAXONOMY LABEL LINKBASE
|
|
|
EX-101.CAL
|
XBRL TAXONOMY EXTENSION CALCULATION
|
|
|
EX-101.DEF
|
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
|
|
MORGAN GROUP HOLDING CO.
|
|
|
By:
|
/s/ Robert E. Dolan
|
|
ROBERT E. DOLAN
|
|
|
Acting Chief Executive Officer/Chief Financial Officer
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|